A citation-based method for searching scientific literature

Liang Zhou, Chong-Yu Shao, Ya-Jun Xie, Na Wang, Si-Min Xu, Ben-Yan Luo, Zhi-Ying Wu, Yue Hai Ke, Mengsheng Qiu, Ying Shen. Elife 2020
Times Cited: 6







List of co-cited articles
15 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Motor skill learning requires active central myelination.
Ian A McKenzie, David Ohayon, Huiliang Li, Joana Paes de Faria, Ben Emery, Koujiro Tohyama, William D Richardson. Science 2014
553
50

Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning.
Lin Xiao, David Ohayon, Ian A McKenzie, Alexander Sinclair-Wilson, Jordan L Wright, Alexander D Fudge, Ben Emery, Huiliang Li, William D Richardson. Nat Neurosci 2016
223
50

Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS.
Qiang Zhu, Xiaofeng Zhao, Kang Zheng, Hong Li, Hao Huang, Zunyi Zhang, Teresa Mastracci, Michael Wegner, Yiping Chen, Lori Sussel,[...]. Development 2014
69
50


NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS.
Mary R L Dawson, Annabella Polito, Joel M Levine, Richard Reynolds. Mol Cell Neurosci 2003
587
33

Cell cycle dynamics of NG2 cells in the postnatal and ageing brain.
Konstantina Psachoulia, Francoise Jamen, Kaylene M Young, William D Richardson. Neuron Glia Biol 2009
153
33


Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain.
Ethan G Hughes, Shin H Kang, Masahiro Fukaya, Dwight E Bergles. Nat Neurosci 2013
421
33


Oligodendrocyte Development and Plasticity.
Dwight E Bergles, William D Richardson. Cold Spring Harb Perspect Biol 2015
217
33

Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
Jessica L Fletcher, Rhiannon J Wood, Jacqueline Nguyen, Eleanor M L Norman, Christine M K Jun, Alexa R Prawdiuk, Melissa Biemond, Huynh T H Nguyen, Susan E Northfield, Richard A Hughes,[...]. J Neurosci 2018
29
33


Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
Hema Mohan, Anita Friese, Stefanie Albrecht, Markus Krumbholz, Christina L Elliott, Ariel Arthur, Ramesh Menon, Cinthia Farina, Andreas Junker, Christine Stadelmann,[...]. Acta Neuropathol Commun 2014
26
33

Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling.
Kaylene M Young, Konstantina Psachoulia, Richa B Tripathi, Sara-Jane Dunn, Lee Cossell, David Attwell, Koujiro Tohyama, William D Richardson. Neuron 2013
513
33

Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system.
Sueli Marques, Amit Zeisel, Simone Codeluppi, David van Bruggen, Ana Mendanha Falcão, Lin Xiao, Huiliang Li, Martin Häring, Hannah Hochgerner, Roman A Romanov,[...]. Science 2016
402
33

Nrf2 deficiency increases oligodendrocyte loss, demyelination, neuroinflammation and axonal damage in an MS animal model.
Anna Nellessen, Stella Nyamoya, Adib Zendedel, Alexander Slowik, Christoph Wruck, Cordian Beyer, Athanassios Fragoulis, Tim Clarner. Metab Brain Dis 2020
11
16


Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology.
Benjamin V Ineichen, Sandra Kapitza, Christiane Bleul, Nicolas Good, Patricia S Plattner, Maryam S Seyedsadr, Julia Kaiser, Marc P Schneider, Björn Zörner, Roland Martin,[...]. Acta Neuropathol 2017
24
16


The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
P Gergely, B Nuesslein-Hildesheim, D Guerini, V Brinkmann, M Traebert, C Bruns, S Pan, N S Gray, K Hinterding, N G Cooke,[...]. Br J Pharmacol 2012
185
16

Oxidative stress disrupts oligodendrocyte maturation.
Heather Morein French, Mary Reid, Polina Mamontov, Rebecca A Simmons, Judith B Grinspan. J Neurosci Res 2009
110
16


Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.
Hye Jung Kim, Veronique E Miron, Danuta Dukala, Richard L Proia, Samuel K Ludwin, Maria Traka, Jack P Antel, Betty Soliven. FASEB J 2011
78
16

Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk.
Kunio Sugahara, Yasuhiro Maeda, Kyoko Shimano, Akira Mogami, Hirotoshi Kataoka, Kei Ogawa, Kumiko Hikida, Hiroshi Kumagai, Mahoko Asayama, Toshinobu Yamamoto,[...]. Br J Pharmacol 2017
42
16

Siponimod (BAF312) Treatment Reduces Brain Infiltration but Not Lesion Volume in Middle-Aged Mice in Experimental Stroke.
Antje Vogelgesang, Grazyna Domanska, Johanna Ruhnau, Alexander Dressel, Michael Kirsch, Juliane Schulze. Stroke 2019
9
16

Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.
Lindsey Wooliscroft, Ghadah Altowaijri, Andrea Hildebrand, Mary Samuels, Barry Oken, Dennis Bourdette, Michelle Cameron. Mult Scler Relat Disord 2020
12
16

Remyelinating Pharmacotherapies in Multiple Sclerosis.
Riley M Bove, Ari J Green. Neurotherapeutics 2017
27
16


Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
E M Medina-Rodríguez, F J Arenzana, J Pastor, M Redondo, V Palomo, R García de Sola, C Gil, A Martínez, A Bribián, F de Castro. Cell Mol Life Sci 2013
35
16


Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial.
Giancarlo Comi, Ludwig Kappos, Krzysztof W Selmaj, Amit Bar-Or, Douglas L Arnold, Lawrence Steinman, Hans-Peter Hartung, Xavier Montalban, Eva Kubala Havrdová, Bruce A C Cree,[...]. Lancet Neurol 2019
66
16


Metabolism and Disposition of Siponimod, a Novel Selective S1P1/S1P5 Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism.
Ulrike Glaenzel, Yi Jin, Robert Nufer, Wenkui Li, Kirsten Schroer, Sylvie Adam-Stitah, Sjoerd Peter van Marle, Eric Legangneux, Hubert Borell, Alexander D James,[...]. Drug Metab Dispos 2018
19
16


Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Qiao Ling Cui, Jun Fang, Timothy E Kennedy, Guillermina Almazan, Jack P Antel. Glia 2014
41
16

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
Ari J Green, Jeffrey M Gelfand, Bruce A Cree, Carolyn Bevan, W John Boscardin, Feng Mei, Justin Inman, Sam Arnow, Michael Devereux, Aya Abounasr,[...]. Lancet 2017
186
16

Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers.
Jianfeng Xu, Frank Gray, Alex Henderson, Kirsty Hicks, Jiansong Yang, Paul Thompson, Johann Oliver. Clin Pharmacol Drug Dev 2014
26
16

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
338
16

Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival.
C Jaillard, S Harrison, B Stankoff, M S Aigrot, A R Calver, G Duddy, F S Walsh, M N Pangalos, N Arimura, K Kaibuchi,[...]. J Neurosci 2005
246
16

Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod.
Veronique E Miron, Jeffery A Hall, Timothy E Kennedy, Betty Soliven, Jack P Antel. Am J Pathol 2008
82
16

Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.
Ruben van Doorn, Melissa A Lopes Pinheiro, Gijs Kooij, Kim Lakeman, Bert van het Hof, Susanne M A van der Pol, Dirk Geerts, Jack van Horssen, Paul van der Valk, Elizabeth van der Kam,[...]. J Neuroinflammation 2012
81
16

Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.
C G Jung, H J Kim, V E Miron, S Cook, T E Kennedy, C A Foster, J P Antel, B Soliven. Glia 2007
125
16

Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
F L Scott, B Clemons, J Brooks, E Brahmachary, R Powell, H Dedman, H G Desale, G A Timony, E Martinborough, H Rosen,[...]. Br J Pharmacol 2016
107
16

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis.
Laetitia Pouzol, Luca Piali, Claude Ca Bernard, Marianne M Martinic, Beat Steiner, Martine Clozel. Innov Clin Neurosci 2019
4
25

Autocrine and paracrine roles of sphingosine-1-phosphate.
Sergio E Alvarez, Sheldon Milstien, Sarah Spiegel. Trends Endocrinol Metab 2007
227
16

Effect of fingolimod on oligodendrocyte maturation under prolonged cerebral hypoperfusion.
Ken Yasuda, Takakuni Maki, Satoshi Saito, Yumi Yamamoto, Hisanori Kinoshita, Yoon Kyung Choi, Thiruma Valavan Arumugam, Yun-An Lim, Christopher Li Hsian Chen, Peter Tsun-Hon Wong,[...]. Brain Res 2019
4
25

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial.
Jeffrey A Cohen, Giancarlo Comi, Krzysztof W Selmaj, Amit Bar-Or, Douglas L Arnold, Lawrence Steinman, Hans-Peter Hartung, Xavier Montalban, Eva Kubala Havrdová, Bruce A C Cree,[...]. Lancet Neurol 2019
69
16

The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.
A Slowik, T Schmidt, C Beyer, S Amor, T Clarner, M Kipp. Br J Pharmacol 2015
71
16

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Peter A Calabresi, Ernst-Wilhelm Radue, Douglas Goodin, Douglas Jeffery, Kottil W Rammohan, Anthony T Reder, Timothy Vollmer, Mark A Agius, Ludwig Kappos, Tracy Stites,[...]. Lancet Neurol 2014
513
16

Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
SunJa Kim, Jacek Bielawski, Hyunmin Yang, Yu Kong, Beiyan Zhou, Jianrong Li. Glia 2018
23
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.